SonoThera

SonoThera is a privately held biotechnology company focused on developing a next-generation approach to genetic medicine using ultrasound-mediated, non-viral gene delivery. The company is working to address one of the major limitations in current gene therapy: the safe and efficient delivery of genetic material into specific tissues in the human bo... dy without relying on viral vectors. Traditional gene therapies often use engineered viruses to transport DNA or RNA into cells, but these methods can face challenges such as immune responses, limited cargo capacity, and manufacturing complexity. SonoThera is developing a platform that instead uses focused ultrasound energy combined with specially designed therapeutic constructs to temporarily increase cell membrane permeability, enabling genetic material to enter targeted tissues in a controlled and repeatable manner.Read More